Michael Oberreiter

Michael Oberreiter is Head of Global Access at F. Hoffmann-La Roche Ltd., based in Basel. He is an economist by training and completed a post-graduate diploma and master studies in International Politics and Communications. Michael has been involved in the field of health policy, patient access, capacity building and health economics for over 25 years. His experience spans across different therapeutic areas, countries – including Austria, Germany, Hungary and Asia Pacific (APAC) where he was responsible for driving the development of creative but solid policy and access strategies to demonstrate the value of, and broaden, sustainable access to Roche products in the region. Michael joined Roche in 2013 with the task of managing market access after the introduction of AMNOG in Germany. Prior to this, Michael held a number of senior positions within the research based and the generic industry, including General Secretary of national industry associations. Michael has held senior commercial positions in several companies related to access and was responsible for developing and implementing sustainable access strategies for established brands and pipeline products and for reimbursement negotiations with payers. He also led global stakeholder management and led cross-functional access and patient advocacy teams. His main areas of professional interest comprise behavioral economics, healthcare system analysis, funding and organization of health services and population health impact.